- The roll-out was planned for early last year but has been postponed several times.
- In 2018, there were 5,250 cases of cervical cancer and 3,286 deaths in Kenya, according to the Ministry of Health.
- The government expects to provide it to 800,000 girls per year, shouldering 15 per cent of the cost, to begin with.
The long-awaited launch of the human papillomavirus (HPV) vaccination is expected to take place in Mombasa Friday.
By launching the highly publicised vaccine, Kenya will join 10 other African countries.
Although two HPV vaccines are currently prequalified by the World Health Organisation (WHO) – a bivalent and a quadrivalent vaccine. In Kenya, the vaccine that will be given Gardasil, also known as Gardisil or Silgard or recombinant human papillomavirus vaccine [types 6, 11, 16, 18], is a vaccine for use in the prevention of certain strains of human papillomavirus, specifically HPV types 6, 11, 16 and 18.